These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 16102793)

  • 21. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
    Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
    Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
    Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
    Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.
    Laman H; Funes JM; Ye H; Henderson S; Galinanes-Garcia L; Hara E; Knowles P; McDonald N; Boshoff C
    EMBO J; 2005 Sep; 24(17):3104-16. PubMed ID: 16096642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
    Horton LE; Templeton DJ
    Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-density growth arrest in Ras-transformed cells: low Cdk kinase activities in spite of absence of p27(Kip) Cdk-complexes.
    Groth A; Willumsen BM
    Cell Signal; 2005 Sep; 17(9):1063-73. PubMed ID: 15993748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of the cyclin-dependent kinase inhibitors p21(Cip1) and p27(Kip1) by phosphorylation directed by the cyclin encoded by Murine Herpesvirus 68.
    Yarmishyn A; Child ES; Elphick LM; Mann DJ
    Exp Cell Res; 2008 Jan; 314(1):204-12. PubMed ID: 17997402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
    Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1).
    Franzén A ; Heldin NE
    Biochem Biophys Res Commun; 2001 Jul; 285(3):773-81. PubMed ID: 11453659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cell cycle kinases.
    Pines J
    Semin Cancer Biol; 1994 Aug; 5(4):305-13. PubMed ID: 7803767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1.
    Godden-Kent D; Talbot SJ; Boshoff C; Chang Y; Moore P; Weiss RA; Mittnacht S
    J Virol; 1997 Jun; 71(6):4193-8. PubMed ID: 9151805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2.
    Ojala PM; Yamamoto K; Castaños-Vélez E; Biberfeld P; Korsmeyer SJ; Mäkelä TP
    Nat Cell Biol; 2000 Nov; 2(11):819-25. PubMed ID: 11056537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases.
    Wang Y; Prives C
    Nature; 1995 Jul; 376(6535):88-91. PubMed ID: 7596441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells.
    Welcker M; Lukas J; Strauss M; Bartek J
    Cancer Res; 1998 Nov; 58(22):5053-6. PubMed ID: 9823309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone H1(S)-3 phosphorylation in Ha-ras oncogene-transformed mouse fibroblasts.
    Chadee DN; Peltier CP; Davie JR
    Oncogene; 2002 Dec; 21(55):8397-403. PubMed ID: 12466960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.